Sai Life Sciences and Lupin Stocks Rise on Strong Business Outlooks and Market Performance

Shares of Sai Life Sciences and Lupin have recently reached new highs amid positive business outlooks. Sai Life Sciences, a contract research and manufacturing firm, saw its stock rise nearly 2% intraday, outperforming the market by 25% over the past month. Lupin's stock gained 2%, hitting a 52-week high, supported by strong quarterly results and regulatory approvals. Both companies benefit from robust demand in regulated markets like the US and Europe, contributing to their recent stock performance amid mixed broader market trends.